251 related articles for article (PubMed ID: 33479240)
1. SVIP is a molecular determinant of lysosomal dynamic stability, neurodegeneration and lifespan.
Johnson AE; Orr BO; Fetter RD; Moughamian AJ; Primeaux LA; Geier EG; Yokoyama JS; Miller BL; Davis GW
Nat Commun; 2021 Jan; 12(1):513. PubMed ID: 33479240
[TBL] [Abstract][Full Text] [Related]
2. The heterozygous R155C VCP mutation: Toxic in humans! Harmless in mice?
Clemen CS; Winter L; Strucksberg KH; Berwanger C; Türk M; Kornblum C; Florin A; Aguilar-Pimentel JA; Amarie OV; Becker L; Garrett L; Hans W; Moreth K; Neff F; Pingen L; Rathkolb B; Rácz I; Rozman J; Treise I; Fuchs H; Gailus-Durner V; de Angelis MH; Vorgerd M; Eichinger L; Schröder R
Biochem Biophys Res Commun; 2018 Sep; 503(4):2770-2777. PubMed ID: 30100055
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
[TBL] [Abstract][Full Text] [Related]
4. Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants.
Zhang T; Mishra P; Hay BA; Chan D; Guo M
Elife; 2017 Mar; 6():. PubMed ID: 28322724
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic variability in three families with valosin-containing protein mutation.
Spina S; Van Laar AD; Murrell JR; Hamilton RL; Kofler JK; Epperson F; Farlow MR; Lopez OL; Quinlan J; DeKosky ST; Ghetti B
Eur J Neurol; 2013 Feb; 20(2):251-8. PubMed ID: 22900631
[TBL] [Abstract][Full Text] [Related]
6. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
[TBL] [Abstract][Full Text] [Related]
7. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
[TBL] [Abstract][Full Text] [Related]
9. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.
Bartolome F; Wu HC; Burchell VS; Preza E; Wray S; Mahoney CJ; Fox NC; Calvo A; Canosa A; Moglia C; Mandrioli J; Chiò A; Orrell RW; Houlden H; Hardy J; Abramov AY; Plun-Favreau H
Neuron; 2013 Apr; 78(1):57-64. PubMed ID: 23498975
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin- and ATP-dependent unfoldase activity of P97/VCP•NPLOC4•UFD1L is enhanced by a mutation that causes multisystem proteinopathy.
Blythe EE; Olson KC; Chau V; Deshaies RJ
Proc Natl Acad Sci U S A; 2017 May; 114(22):E4380-E4388. PubMed ID: 28512218
[TBL] [Abstract][Full Text] [Related]
12. A Brazilian family with inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia linked to the VCP pGly97Glu mutation.
Shinjo SK; Oba-Shinjo SM; Lerario AM; Marie SKN
Clin Rheumatol; 2018 Apr; 37(4):1129-1136. PubMed ID: 29127544
[TBL] [Abstract][Full Text] [Related]
13. The multifaceted clinical presentation of VCP-proteinopathy in a Greek family.
Papadimas GK; Paraskevas GP; Zambelis T; Karagiaouris C; Bourbouli M; Bougea A; Walter MC; Schumacher NU; Krause S; Kapaki E
Acta Myol; 2017 Dec; 36(4):203-206. PubMed ID: 29770363
[TBL] [Abstract][Full Text] [Related]
14. Different dynamic movements of wild-type and pathogenic VCPs and their cofactors to damaged mitochondria in a Parkin-mediated mitochondrial quality control system.
Kimura Y; Fukushi J; Hori S; Matsuda N; Okatsu K; Kakiyama Y; Kawawaki J; Kakizuka A; Tanaka K
Genes Cells; 2013 Dec; 18(12):1131-43. PubMed ID: 24215292
[TBL] [Abstract][Full Text] [Related]
15. Valosin-containing protein (VCP) is a novel IQ motif-containing GTPase activating protein 1 (IQGAP1)-interacting protein.
Itoh N; Nagai T; Watanabe T; Taki K; Nabeshima T; Kaibuchi K; Yamada K
Biochem Biophys Res Commun; 2017 Dec; 493(4):1384-1389. PubMed ID: 28970065
[TBL] [Abstract][Full Text] [Related]
16. [A patient with familial amyotrophic lateral sclerosis associated with a new valosin-containing protein (VCP) gene mutation].
Segawa M; Hoshi A; Naruse H; Kuroda M; Bujo H; Ugawa Y
Rinsho Shinkeigaku; 2015; 55(12):914-20. PubMed ID: 26511028
[TBL] [Abstract][Full Text] [Related]
17. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice.
Rodriguez-Ortiz CJ; Hoshino H; Cheng D; Liu-Yescevitz L; Blurton-Jones M; Wolozin B; LaFerla FM; Kitazawa M
Am J Pathol; 2013 Aug; 183(2):504-15. PubMed ID: 23747512
[TBL] [Abstract][Full Text] [Related]
18. Motor neuron involvement in multisystem proteinopathy: implications for ALS.
Benatar M; Wuu J; Fernandez C; Weihl CC; Katzen H; Steele J; Oskarsson B; Taylor JP
Neurology; 2013 May; 80(20):1874-80. PubMed ID: 23635965
[TBL] [Abstract][Full Text] [Related]
19. A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family.
Gu JM; Ke YH; Yue H; Liu YJ; Zhang Z; Zhang H; Hu WW; Wang C; He JW; Hu YQ; Li M; Fu WZ; Zhang ZL
Bone; 2013 Jan; 52(1):9-16. PubMed ID: 23000505
[TBL] [Abstract][Full Text] [Related]
20. A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.
Plewa J; Surampalli A; Wencel M; Milad M; Donkervoort S; Caiozzo VJ; Goyal N; Mozaffar T; Kimonis V
Neuromuscul Disord; 2018 Sep; 28(9):778-786. PubMed ID: 30097247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
